Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Northwest Biotherapeutics Inc (OTCQB:NWBO)

0.25
Delayed Data
As of 3:59pm ET
 +0.021 / +9.17%
Today’s Change
0.14
Today|||52-Week Range
0.98
-28.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues159.0K71.0K68.0K88.0K
 
 
 
 
 
Depreciation And Amortization55.0K54.0K56.0K44.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses25.6M21.3M11.9M10.7M
 
 
 
 
 
Research And Development21.1M16.8M5.0M5.5M
 
 
 
 
 
Total Operating Expenses25.7M21.3M12.0M10.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.5M-21.2M-11.9M-10.7M
 
 
 
 
 
Extraordinary Credit0.00653.0K1.4M6.5M
 
 
 
 
Extraordinary Charge-2.1M-6.4M-1.5M-7.0M
 
 
 
 
 
Interest Expense On Debt691.0K1.7M1.2M1.3M
 
 
 
 
 
Other Expenses-913.0K-2.0M574.0K2.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-29.2M-30.7M-12.6M-10.3M
 
 
 
 
 
Net Income-32.2M-30.7M-12.6M-10.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS114.8M122.8M161.5M208.5M
 
 
 
 
 
Shares To Calculate EPS Diluted114.8M122.8M161.5M208.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.28-$0.25-$0.08-$0.05
 
 
 
 
 
EPS Diluted-$0.28-$0.25-$0.08-$0.05